Type 1 diabetes is one of the most common chronic diseases diagnosed in childhood and affects up to 5000 children and adolescents in Aotearoa New Zealand.
Unlike type 2 diabetes, type 1 diabetes is an auto-immune disease. Cells in the pancreas which help control blood glucose levels (by secreting insulin) are destroyed by the immune system and therefore people who develop this disease have a considerable life-long burden of managing their glucose levels.
A range of type 1 diabetes-focused projects are undertaken by EDOR researchers, including clinical trials for new treatment and management options for children, adolescents, and adults living with this disease.
- The Co-Pilot trial
- OPTIMISE study
- Closed loop therapy study for youth with type 1 diabetes
- Flash-2 Study for type 1 diabetes in children
- Managing diabetes in a "flash"
- SKIDDoo Study
- Discontinued insulin pump therapy
- Glycaemic control and Type 1 diabetes mellitis (T1DM)